OMER FY 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+55.8% YoY

Gross Profit

$64M98.3% margin

Operating Income

-$44M-67.7% margin

Net Income

-$53M-82.5% margin

EPS (Diluted)

$-1.17

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$116M

Total Liabilities

$119M

Stockholders' Equity

-$3M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$42M	+55.8%
Gross Profit	$64M	$40M	+58.6%
Operating Income	-$44M	-$54M	+19.1%
Net Income	-$53M	-$67M	+19.9%